Literature DB >> 4632594

Agents stimulating gonadal function in the human. Report of a WHO scientific group.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4632594

Source DB:  PubMed          Journal:  World Health Organ Tech Rep Ser        ISSN： 0512-3054


× No keyword cloud information.
  11 in total

1.  Effects of Anticoagulants and Immune Agents on Pregnancy Outcomes and Offspring Safety in Frozen-Thawed Embryo Transfer Cycles-A Retrospective Cohort Study.

Authors:  Yanli Fan; Yizhuo Wang; Zhuoye Luo; Yueming Xu; Jie Zhang; Wei Wang; Na Cui; Guimin Hao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-21       Impact factor: 6.055

2.  Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients.

Authors:  J Balasch; F Fábregues; J Peñarrubia; M Creus; R Vidal; R Casamitjana; D Manau; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  1998-10       Impact factor: 3.412

3.  The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: evidence from a large multicenter study in Spain.

Authors:  J Balasch; R Tur; P Alvarez; J M Bajo; E Bosch; I Bruna; P Caballero; J Calaf; I Cano; E Carrillo; J A Duque; G Folguera; A de la Fuente; C Jiménez; G Laguens; E López; A Lozano; A Matarranz; C Moreno; J Nava; M Sanchis; E Temprano; G Ventura; J A Peinado
Journal:  J Assist Reprod Genet       Date:  1996-08       Impact factor: 3.412

4.  Gonadotropin releasing hormone agonists: Expanding vistas.

Authors:  Navneet Magon
Journal:  Indian J Endocrinol Metab       Date:  2011-10

5.  Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity.

Authors:  Robert J Norman; Fernando Zegers-Hochschild; Bruno S Salle; Jolanda Elbers; Esther Heijnen; Maya Marintcheva-Petrova; Bernadette Mannaerts
Journal:  Hum Reprod       Date:  2011-05-27       Impact factor: 6.918

6.  Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study.

Authors:  Sigal Kaplan; Rachel Levy-Toledano; Miranda Davies; Debabrata Roy; Colin M Howles; Amir Lass
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-16       Impact factor: 5.555

7.  A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol.

Authors:  P Devroey; R Boostanfar; N P Koper; B M J L Mannaerts; P C Ijzerman-Boon; B C J M Fauser
Journal:  Hum Reprod       Date:  2009-08-14       Impact factor: 6.918

Review 8.  Volume expanders for the prevention of ovarian hyperstimulation syndrome.

Authors:  Mohamed A Youssef; Selma Mourad
Journal:  Cochrane Database Syst Rev       Date:  2016-08-31

Review 9.  Optimal management of subfertility in polycystic ovary syndrome.

Authors:  Joshua J Berger; G Wright Bates
Journal:  Int J Womens Health       Date:  2014-06-13

10.  Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.

Authors:  Georg Griesinger; Pierre J M Verweij; Davis Gates; Paul Devroey; Keith Gordon; Barbara J Stegmann; Basil C Tarlatzis
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.